A Rare Cause of Drug-Induced Pancytopenia: Trimethoprim-Sulfamethoxazole-Induced Pancytopenia

Khalid Sawalha1, Philip T Sobash1, Gilbert-Roy Kamoga1

  • 1Internal Medicine Division, White River Health System, Batesville, AR 72501, USA.

Insights

Pancytopenia, a drop in blood cell counts, can stem from various causes. This case highlights trimethoprim-sulfamethoxazole (TMP-SMX) as a potential drug-induced pancytopenia trigger, resolving upon discontinuation.

Area of Science:

  • Hematology
  • Pharmacology
  • Internal Medicine

Background:

  • Pancytopenia is a significant hematological condition characterized by a reduction in all three major blood cell lines.
  • Etiologies are diverse, encompassing infections, toxins, malignancy, and medications.
  • Identifying the cause is crucial for timely and effective management.

Observation:

  • A case of pancytopenia was observed.
  • The patient was administered trimethoprim-sulfamethoxazole (TMP-SMX).
  • The onset, timing, and severity suggested an iatrogenic cause.

Findings:

  • Drug-induced pancytopenia secondary to TMP-SMX was diagnosed.
  • Cessation of TMP-SMX led to rapid recovery of hematological cell lines.
  • TMP-SMX is an underreported cause of drug-induced pancytopenia.

Implications:

  • Clinicians should consider TMP-SMX as a potential cause of pancytopenia.
  • Prompt discontinuation of the offending agent is key for patient recovery.
  • Further investigation into TMP-SMX's hematotoxicity is warranted.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.3K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
56
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
435
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
61
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
295
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
1.5K